MycoBiomDB – Record Details (MyCo_5304)

Biomarker Record Details

Database ID: MyCo_5304
DB IDMyCo_5304
TitleIntrathecal IgG Synthesis and Persistent Inflammation Are Associated with White Matter Lesions in HIV-negative Patients with Cryptococcal Meningoencephalitis
Year2019
PMID31243232
Fungal Diseases involvedCryptococcal meningoencephalitis
Associated Medical ConditionWhite Matter Lesions
GenusCryptococcus
Speciesneoformans
OrganismCryptococcus neoformans
Ethical StatementEach participating hospital received either human research approval to enroll patients without individual patient consent under the Common Rule or a waiver of authorization and exemption from subsequent review by the ethics committees of Tokyo Medical and Dental University, Yokosuka Kyosai Hospital, and Tsuchiura Kyodo General Hospital. The study was conducted in compliance with the Declaration of Hel-sinki.
Site of InfectionNone
Opportunistic invasiveNone
Sample typeBody fluid
Sample sourceCerebrospinal fluid (CSF)
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameCSF IgG
Biomarker Full NameCerebrospinal fluid immunoglobulin G
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationJapan
CohortThis was a retrospective study conducted in Japan at Tokyo Medical and Dental University, Yokosuka Kyosai Hospital and Tsuchiura Kyodo General Hospital between April 2001 and March 2018. Eleven consecutive HIV-negative patients with CM who presented at one of three emergency hospitals in Japan from April 2001 to March 2018 were enrolled.
Cohort No.11
Age Group29-89
P ValueNone
SensitivityNone
SpecificityNone
Positive Predictive ValueNone
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismCryptococcal meningoencephalitis (CM) is a life- threatening fungal infection of the central nervous system (CNS). Although CM is common in human immunodefi-ciency virus (HIV)-positive patients, HIV-negative CM pa-tients have also been increasingly frequently encountered be-cause of the widespread use of immunologic drugs againstcancers and autoimmune disorders and the prevalence of diabetes mellitus, chronic liver and renal diseases especially in developed countries.
TechniqueAnalytic
Analysis MethodMRI (magnetic resonance imaging)
ELISA kitsNone
Assay DataNone
Validation Techniques usedMRI Analysis
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone